Asia Pacific Drug Formulation &

Bioavailability Congress
September 05-07, 2016
Beijing, China
Theme: Advanced Drug Formulation
perspectives for Comprehensive Bioavailability

Conference Venue

DoubleTree by Hilton Beijing

168 Guang An Men Wai Avenue,
Xi Cheng District
Beijing, China

Conference Dates:
September,05-07, 2016

About Conference

Drug formulation-2016 welcomes Students, Pharmaceutical companies /

industries, leading universities and research institutions, presenters, and
exhibitors from all over the world to Beijing, China. We are delighted to
invite you all to attend and register for the Asia Pacific Drug Formulation &
Bioavailability Congress (Drug formulation -2016) which is going to be
held during September 05-07,2016 at Beijing, China. We invite you to join
us at the Drug Formulation 2016, where you will be sure to have a
meaningful experience with scholars from around the world. All members
of the Drug Formulation 2016 organizing committee look forward to
meeting you in Beijing, China.
OMICSInternational Organizes 300+ Conferences Every Year across
USA, Europe & Asia with support from 1000 more scientific societies and
Publishes 400+ Open access journals which contains over 30000 eminent
personalities, reputed scientists as editorial board members.

Market Analysis
Why China?
China is currently the third largest pharmaceutical market in the world, posting $67
billion in revenue in 2011. With an anticipated compound growth rate of 24%
between 2010 and 2020, China is expected to be the second largest market by
2015. Currently, there are about 1,400 drug companies in China that are,
collectively, able to produce more than 60 dosage forms and about 5,000 different
types of medicines. The current Chinese market value of the dosage form medicines
is worth about $50 B, accounting for about 5.7% of the global market value.
Internally, aiming to transform the Chinese pharmaceutical industry, the Chinese
government is encouraging the Chinese drug companies to upgrade their
manufacturing facility and improve their product quality. It is therefore believed that
the Chinese dosage form drug market will continue to grow in a fast pace. It is
expected to likely experience a CAGR of about 25% in the next five years. Its
market value could reach more than $158bn in 2016, and expand to 2023

Market Analysis

The global generics sector reached $269.8 billion in 2012. This sector
is expected to reach $300.9 billion in 2013 and $518.5 billion in 2018,
with a compound annual growth rate (CAGR) of 11.5%.
An overview of the global market for generic drug including coverage
of therapeutic
Analyses of global market trends, with data from 2012, estimates for
2013, and projections of compound annual growth rates (CAGRs)
through 2018.The North American market is estimated to reach nearly
$73 billion in 2011 and is expected to increase at a 7.9% compound
annual growth rate to reach nearly $107 billion in 2016.
The United States is currently spending almost $250 billion a year for
prescription drugs. If drugs were sold in a competitive market, without
government-imposed patent monopolies, this might achieve savings
up to $200 billion a year.

Conference Highlights

Preformulation & Formulation

Biopharmaceutics
Classification System

Drug Formulation Procedures

Bioavailability Studies &

Factors Affecting
Bioavailability

Novel Drug Delivery System & Nutrient & Advances In

Stability Studies
Bioavailability
Drug Product Manufacturing

Medicinal Chemistry &

Traditional Medicine

Analytical Method
Development

Clinical Studies & Contract

Research Organizations

Special Issues [OMICS Journals]

All accepted abstracts will be
published in respective OMICS
International Journals.
Journal of Pharmaceutics & Drug Delivery
Research
Drug Designing
Journal of Developing Drugs
Journal of Bioequivalence & Bioavailability
Abstracts will be provided with Digital
Object Identifier by

Special Benefits

All accepted abstracts will be published in the

respective Journal
Abstracts will receive a (DOI) provided by CrossRef
Special privileges on group registrations
Opportunity to organize Workshop/Symposia
Global Exposure to your Research
Best poster competition
Young researcher competitions

Organising Committee
members:
Abdulmohsen H. Alrohaimi, Dean, School of Pharmacy,
University in Shaqraa, Saudi Arabia.
Peng Li, Scientist in Medicine, University of California, Canada
Weiguo Dai, Scientific Director for Johnson &Johnson , USA
Sinerik Ayrapetyan, Professor in UNESCO, Armenia
Duc P. Do, Associate Professor at Chicago State University
College of Pharmacy, USA
Ibrahim Al-Khars, President at AlAhsa Pharmacy Club, Saudi
Pharmaceutical Society, Saudi Arabia
M. Fawzi Mahomoodally, Professor at University of Mauritius,
Mauritius.

Exhibition
Why to attend Drug Formulation 2016?
Best platform to develop new partnership & collaborations.
Best location to speed up your route into every territory in the
World.
89% our conference attendees are the Key contact in their
labs purchasing decisions.
Our exhibitor booths were visited 4-5 times by 80% of the
attendees during the conference.
Past exhibitors feedback reveals ample of enquiries
perceived from the conference attendees.
Network development with both Academia and Business.

Be a member and support

us

Join Our Mailing List

Suggest A Speaker
Suggestions
Invite Proposals